Rare diseases
Investigational molecules
Locations
Back to Spain1 052 clinical trials in Malaga, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors
SpainStudy Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy
SpainStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
SpainStudy on the Effectiveness of Heated Chemotherapy with Mitomycin-C for Patients with Colon Cancer Spread to the Peritoneum After Surgery
SpainStudy Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients
SpainStudy on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism
SpainLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
SpainSpainStudy of Talazoparib and Enzalutamide combination treatment for patients with metastatic prostate cancer who previously received Abiraterone
SpainStudy on the Effectiveness of Niraparib Rechallenge After Surgery in Ovarian Cancer Patients with Limited Metastasis
SpainStudy of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels
SpainStudy Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations
SpainThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for cutaneous lupus erythematosus and myasthenia gravis, evaluating new therapeutic approaches to improve patient outcomes.
Studies aim to assess novel therapies' effectiveness in reducing disease activity and improving daily living activities.
Innovative vaccine development studies targeting COVID-19, cytomegalovirus, and respiratory syncytial virus, focusing on prevention and immune response.
Research emphasizes safety and immunogenicity in various population groups.
Advanced studies in bladder cancer, colorectal cancer, and gastric cancer, evaluating targeted therapies and combination treatments.
Trials focus on improving survival rates and treatment responses in various cancer types.
Research examining new treatments for chronic rhinosinusitis and COPD, with emphasis on symptom management and exacerbation prevention.
Studies evaluate novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
